Abstract
OBJECTIVE: To develop a value assessment index system of anti-tumour commercial Chinese polyherbal preparation (CCPP). METHODS: A modified two-round Delphi method was conducted to establish consensus within a field to reach an agreement via questionnaire among a multidisciplinary panel of experts. In addition, the analytic hierarchy process was used to conduct weight analysis of indicators. RESULTS: In two rounds of Delphi consultation, the experts' positive coefficient was over 90%, and the authoritative coefficient was over 0.70. The Kendall's W of two rounds was 0.401 and 0.438, and the P-value of Kendall's W test was all <0.001 for each round. The final value assessment index system consisted of 7 primary indicators, 24 secondary indicators, and 50 tertiary indicators. CONCLUSION: This value assessment index system could promote the clinical rational use of CCPP and the development of the drug catalog and clinical guideline in China.